Answer
Glofitamab (Columvi) is not recommended during pregnancy or in women of childbearing potential not using contraception, as it may harm the foetus and is likely to cause foetal B-cell depletion.
Sources for this answer
- Columvi 2.5 mg, 10 mg concentrate for solution for infusionRoche Products Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 6Document updated
Sources checked